What are Phytotherapeutic drugs?

Phytotherapeutic drugs are pharmacologic agents that share a common mechanism (typically targeting 5-alpha-reductase). 0 are currently marketed, with 4 more in clinical development.

Phytotherapeutic

0 marketed 3 in Phase 3 1 in Phase 2

This page covers all Phytotherapeutic drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting 5-alpha-reductase.

Targets

5-alpha-reductase

Phase 3 pipeline (3)

Saw Palmetto - first 24 weeks · University of Alabama at Birmingham · Urology
Saw palmetto may inhibit the conversion of testosterone to dihydrotestosterone (DHT), a hormone involved in hair loss and prostate issues.
Saw Palmetto - weeks 48 - 72 · University of Alabama at Birmingham · Urology
Saw palmetto may inhibit the conversion of testosterone to dihydrotestosterone (DHT), a hormone involved in hair loss and prostate issues.
Saw Palmetto - weeks 24 - 48 · University of Alabama at Birmingham · Urology
Saw palmetto may inhibit the conversion of testosterone to dihydrotestosterone (DHT), a hormone linked to benign prostatic hyperplasia (BPH).

Phase 2 pipeline (1)

Ginkgo biloba extract EGb 761 · VSM Geneesmiddelen b.v. · Neurology
Ginkgo biloba extract EGb 761 is believed to improve blood flow to the brain by increasing nitric oxide production and reducing platelet aggregation.